Farther Finance Advisors’s Abeona Therapeutics ABEO Stock Holding History

Farther Finance Advisors’s Portfolio ABEO Stock Details ABEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$2.83K	Sell	540 -126	-19%	-$782	﹤0.01%	5270
2026 Q2	$4.12K	Buy	666 +48	+8%	+$264	﹤0.01%	4892
2026 Q1	$2.83K	Sell	618 -1,506	-71%	-$7.53K	﹤0.01%	4759
2025 Q4	$11.2K	Buy	2,124 +1,401	+194%	+$7.05K	﹤0.01%	3832
2025 Q3	$3.82K	Buy	723 +343	+90%	+$2.17K	﹤0.01%	3880
2025 Q2	$2.16K	Buy	+380	New	+$2.16K	﹤0.01%	3673

Other funds holding ABEO

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

Farther Finance Advisors's ABEO Position: Q3 2026 in Review

Farther Finance Advisors reduced its Abeona Therapeutics (ABEO) stake by 19% in Q3 2026, selling an estimated $782 and leaving 540 shares worth $2.83K. The position accounts for ﹤0.01% of the portfolio, ranked #5270.

Farther Finance Advisors first reported a position in ABEO in Q2 2025 and has held it in 6 quarters since. The position peaked at $11.2K in Q4 2025. 2 funds tracked by Wall St. Rank hold ABEO as of Q3 2026.

Farther Finance Advisors held 540 shares of Abeona Therapeutics worth $2.83K as of Q3 2026.
Farther Finance Advisors sold 126 Abeona Therapeutics shares in Q3 2026, an estimated $782.
Abeona Therapeutics made up ﹤0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #5270 holding.
Farther Finance Advisors first reported a position in Abeona Therapeutics in Q2 2025 and has held it in 6 quarters since.
Farther Finance Advisors's Abeona Therapeutics position peaked at $11.2K in Q4 2025.
2 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.